Tekla Life Sciences Stock Technical Analysis
| HQL Stock | USD 13.79 0.04 0.29% |
As of the 25th of November, Tekla Life has the Coefficient Of Variation of (1,379), risk adjusted performance of (0.05), and Variance of 1.34. Tekla Life technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Tekla Life Sciences standard deviation and value at risk to decide if Tekla Life is priced more or less accurately, providing market reflects its prevalent price of 13.79 per share. Given that Tekla Life Sciences has information ratio of (0.19), we advise you to double-check Tekla Life Sciences's current market performance to make sure the company can sustain itself at a future point.
Tekla Life Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Tekla, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TeklaTekla |
Tekla Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Tekla Life Sciences Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Tekla Life Sciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Tekla Life Sciences Trend Analysis
Use this graph to draw trend lines for Tekla Life Sciences. You can use it to identify possible trend reversals for Tekla Life as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Tekla Life price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Tekla Life Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Tekla Life Sciences applied against its price change over selected period. The best fit line has a slop of 0.01 , which may imply that the returns on investment in Tekla Life Sciences will continue to fail. It has 122 observation points and a regression sum of squares at 4.74, which is the sum of squared deviations for the predicted Tekla Life price change compared to its average price change.About Tekla Life Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Tekla Life Sciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Tekla Life Sciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Tekla Life Sciences price pattern first instead of the macroeconomic environment surrounding Tekla Life Sciences. By analyzing Tekla Life's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Tekla Life's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Tekla Life specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Payout Ratio | 1.8E-4 | 1.71E-4 | Days Of Payables Outstanding | 301.91 | 219.7 |
Tekla Life November 25, 2024 Technical Indicators
Most technical analysis of Tekla help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tekla from various momentum indicators to cycle indicators. When you analyze Tekla charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 0.813 | |||
| Coefficient Of Variation | (1,379) | |||
| Standard Deviation | 1.16 | |||
| Variance | 1.34 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 6.65 | |||
| Value At Risk | (1.95) | |||
| Potential Upside | 1.48 | |||
| Skewness | (0.92) | |||
| Kurtosis | 4.44 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Dividend Share 1.3 | Earnings Share 1.34 | Revenue Per Share 0.134 | Quarterly Revenue Growth 0.07 |
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.